Skilled Nursing Facility Characteristics Associated With Financially Motivated Therapy and Relation to Quality

Abstract

ObjectivesIn October 2019, the Centers for Medicare & Medicaid Services (CMS) implemented a new payment model for skilled nursing facilities (SNFs) that eliminated financial incentives to provide high-intensity therapy. Yet high-intensity therapy in SNFs has been linked to better quality outcomes, potentially putting patients at risk if clinically indicated therapy is reduced under the new payment model. A metric to help differentiate between financially motivated vs clinically indicated therapy in SNFs is thresholding: the percentage of patients receiving therapy within 10 minutes of reimbursement thresholds. This study examined which SNF characteristics are associated with thresholding and how thresholding relates to quality outcomes. DesignSecondary analysis of 2016 CMS administrative data. Setting and Participants14,162 SNFs. MethodsSNF Public Use Files, Nursing Home Compare, and Provider of Services files were linked. We used linear regression models to (1) identify SNF characteristics associated with thresholding and (2) determine associations between thresholding and quality outcomes, controlling for SNF and patient characteristics. ResultsThresholding was 6.4 percentage points [95% confidence interval (CI) 5.4, 7.4] higher in SNFs with all contractor therapy staff vs all in-house staff. Compared with nonprofit SNFs, thresholding was 2.5 (95% CI 0.1, 2.9) and 1.6 (95% CI 0.4, 2.9) percentage points higher in governmental and for-profit SNFs, respectively. For each additional therapist per 1000 patient-days, SNFs had 2.9 (95% CI –3.4, −2.4) percentage points lower thresholding. Higher thresholding was significantly associated with worse quality outcomes, including lower rates of functional improvement and community discharge and higher rates of 30-day admissions, but magnitudes were small. Conclusions and ImplicationsSNFs with higher thresholding behavior may respond to changes in financial incentives under the new payment model by reducing clinically indicated therapy and should be monitored to ensure access to necessary therapy is maintained. Although thresholding behavior may indicate cost-intensive therapy practice, it may not have clinically significant implications for patients.